April 13, 2011 – Physician-researchers from the cardiac center at The Children’s Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American College of Cardiology’s 60th Annual Scientific Sessions in New Orleans.

April 13, 2011 – Patient enrollment has begun for the SuperNOVA clinical trial. It will examine the safety and effectiveness of Boston Scientific’s Innova self-expanding bare-metal stent in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).

April 13, 2011 – The U.S. Department of Veteran Affairs (VA) has awarded one of six national contracts to Cardiocom for home telehealth devices and services. Cardiocom will supply VA with its telehealth products and services, including Commander Home Telehealth Monitoring System, Interactive Voice Response System and Omnivisor Patient Management Software.

April 13, 2011 – The American College of Cardiology Foundation (ACCF), American Heart Association (AHA) and the Heart Failure Society of America (HFSA) have released results of a recent survey to determine the current staffing environment of heart failure (HF) clinics and offices focused on heart transplants.

April 13, 2011 – In the fall of 2010, leadership of the American Society of Echocardiography (ASE), physician-scientists active in cardiovascular ultrasound, respected ultrasound physicists and senior engineers from several ultrasound companies came together to brainstorm possible applications for cardiovascular ultrasound.


April 11, 2011 — The following is a roundup of key news and trial data that came out of the American College of Cardiology (ACC) 2011 Scientific Session in New Orleans last week. Transcatheter Valve Repair Performs Very Well

April 9, 2011 - The Resolute zotarolimus-eluting stent using a new biocompatible polymer achieved a lower rate of restenosis and in-stent thrombosis compared to the Endeavor stent at 12 months in a U.S. trial. Data from the RESOLUTE U.S. trial was presented this week at the American College of Cardiology (ACC) Scientific Session in New Orleans.

The RIVAL Trial showed radial access has advantages to femoral access.

April 8, 2011 — In the largest randomized trial to compare radial access and femoral access for coronary angiography and intervention, researchers found radial access reduced rates of vascular complications, according to research presented this week at the American College of Cardiology (ACC) Scientific Session in New Orleans.

April 8, 2011 – In the largest randomized, multicenter trial to compare drug-eluting stents (DES) and bare-metal stents (BMS) placed in saphenous vein graft lesions, researchers found that DES led to a lower combined rate of death, heart attack and repeat revascularization. The research findings were presented this week at the American College of Cardiology’s 60th Annual Scientific Session.

April 8, 2011 – A Canadian research team found that the radial artery outperformed the saphenous vein as the best conduit for coronary artery bypass graft (CABG) surgery. The radial artery also led to reduced rates of functional or complete graft occlusion, according to research presented this week at the American College of Cardiology’s 60th Annual Scientific Session.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now